1
Are unaffected by the virus. There are yet questions unanswered and the virus continues to spread unabated. However these immune components are several key elements attractive targets for study that hopefully can advance the field of research.12.13. 14. 15. 16.Competing interestsThe author declares that they have no competing interests.Authors' informationsDavid Gentry Nielsen was born 27, Septemb
1
Sion Partial Remission 11 (25) Stable Disease 12 (27) Progressive Disease 21 (48) Not assessable 0 (0) Survival (Months) Time to Progression 3.6 Overall Survival 10.0 (0) 9 (60) 5 (33) 1 (7) 0 (0)0 (0) 2 (9) 8 (32) 13 (59) 0 (0)0 (0) 0.002 10 (36) 10 (36) 0.001 8 (30) 0 (0)0 (0) 1 (6) 2 (13) 13 (81) 0 (0) 0.03 0.7.72.9 9.0.6.4 10.3.1 10.0.Only statistically significant p values have been included.
1
Sion Partial Remission 11 (25) Stable Disease 12 (27) Progressive Disease 21 (48) Not assessable 0 (0) Survival (Months) Time to Progression 3.6 Overall Survival 10.0 (0) 9 (60) 5 (33) 1 (7) 0 (0)0 (0) 2 (9) 8 (32) 13 (59) 0 (0)0 (0) 0.002 10 (36) 10 (36) 0.001 8 (30) 0 (0)0 (0) 1 (6) 2 (13) 13 (81) 0 (0) 0.03 0.7.72.9 9.0.6.4 10.3.1 10.0.Only statistically significant p values have been included.
1
Use tissues[47]. There is a high correlation between NS1 concentration in patient sera and high concentrations of anaphylatoxins which suggests a role for NS1 in complement activation. Further, anaphylatoxins are co-localized to the lungs and plasma in dengue infections. Co-localization experiments with membrane bound NS1 and NS1 specific antibodies showed the formation of complement attack comple

What is Kliqqi?

Kliqqi is an open source content management system that lets you easily create your own user-powered website.

Latest Comments